// App-Quantinova.ai

15316 : Paradoxical Reduction in Myocardial Performance When Combining Two Independently Cardioprotective Agents: Mitochondrial-targeted Antioxidant MitoSNO and Adenosine Triphosphate-sensitive Potassium Channel Opener Diazoxide

Researchers

Presenter

  • Jie Wang

Principal Investigators

  • Alex Suarez-Pierre

  • Natalie Gaughan

  • Rosmi Thomas

  • Krisztian Sebestyen

  • Joseph Canner

  • Murphy Mike

  • Jennifer S Lawton

Medical Centers

  • Johns Hopkins Med Sch, Hanover, MD

  • JOHNS HOPKINS UNIVERSITY SOM, Baltimore, MD

  • MRC Mitochondrial Biology Unit and Dept of Medicine, Univ of Cambridge, Cambridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Adenosine-5'-triphosphate

  • Diazoxide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved